Item Details

abstract

Breast cancer is the second most common cause of cancer related death in women. Decades of research have demonstrated complexity and high heterogeneity of this disease. The tumor heterogeneity is a result of many altered genomic, epigenomic, and protein modification states that contribute to a distinctive proliferative advantage. The same deregulations that initiate tumorigenesis of mammary epithelial cells are believed to coerce therapeutic resistance. On the other hand, population-wide screenings have increased diagnosis of women with breast cancers without specificity for the tumors with an aggressive phenotype. Hence, identification of the cancer cell's intrinsic alterations that faithfully predict tumor progression has a potential to significantly improve their clinical management.

subject

ARF

Breast Cancer

DMP1

HER2

p53

Tumor suppressor

contributor

Maglic, Dejan (author)

Sui, Guangchao (committee chair)

Loeser, Richard F (committee member)

Kulik, George (committee member)

Miller, Lance D (committee member)

Pardee, Timothy S (committee member)

date

2014-07-10T08:35:20Z (accessioned)

2015-07-10T08:30:09Z (available)

2014 (issued)

degree

Cancer Biology (discipline)

embargo

2015-07-10 (terms)

identifier

http://hdl.handle.net/10339/39244 (uri)

language

en (iso)

publisher

Wake Forest University

title

Role of Tumor Suppressor DMP1 in the Initiation and Progression of Breast Cancer

type

Dissertation